Valbenazine + Placebo
Phase 3Completed 0 watching 0 views this week📈 Rising
74
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Chorea, Huntington
Conditions
Chorea, Huntington
Trial Timeline
Nov 13, 2019 → Oct 26, 2021
NCT ID
NCT04102579About Valbenazine + Placebo
Valbenazine + Placebo is a phase 3 stage product being developed by Neurocrine Biosciences for Chorea, Huntington. The current trial status is completed. This product is registered under clinical trial identifier NCT04102579. Target conditions include Chorea, Huntington.
Hype Score Breakdown
Clinical
27
Activity
18
Company
7
Novelty
9
Community
10
Clinical Trials (3)
| NCT ID | Phase | Status |
|---|---|---|
| NCT07111988 | Phase 2 | Recruiting |
| NCT05654870 | Phase 3 | Terminated |
| NCT04102579 | Phase 3 | Completed |
Competing Products
2 competing products in Chorea, Huntington
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| Valbenazine | Neurocrine Biosciences | Phase 3 | 74 |
| Valbenazine | Neurocrine Biosciences | Phase 3 | 74 |